In addition to the therapies mentioned above that effectively target HER3 for cancer treatment, some molecules have emerged in recent years and can become future drug design targets for HER3, including E3 ubiquitin ligases, microRNAs, and transcription factors [Figure 3]. The gene discussed is ERBB3; the disease is cancer.